Bolt and Texas Pacific Land aim to attract hyperscalers with bespoke land, power, and water services for data center campuses.

From agentic payments to cybersecurity threats and workplace automation, top executives share their predictions for how AI ...

More plans for data center development in West Texas have been announced. Texas Pacific Land Corp. has made a strategic agreement with Data & Energy Inc. to develop and enable large-scale data center ...

LOS ANGELES (KABC) -- This might sound familiar: Chevrolet is coming out with a new electric car called the Bolt. Okay, technically they're bringing back the Bolt for 2027, after it was dropped a ...

With a starting price below $30,000, including the destination charge, the 2027 Chevrolet Bolt will be among the most affordable electric vehicles (EVs) on the market when it debuts in early 2026.

General Motors is releasing a redesigned version of the Chevrolet Bolt EV in 2026. The EV features a new battery and better charging capabilities among several upgrades. Can automakers produce a brand ...

View post: Should Dodge Revive the AMC Pacer as a Retro EV Hot Hatch to Take on the Hyundai Ioniq 5? While the 2027 Bolt’s exterior design is similar to the 2023 Bolt EUV, it offers improvements ...

Earlier this morning, some of the first details of the new 2027 Chevrolet Bolt percolated out onto the internet thanks to some people that attended a special preview for existing owners last night in ...

GM is bringing back its Chevrolet Bolt with a new model that it expects to account for much of its electric-vehicle volume next year. The company said Thursday its 2027 Chevrolet Bolt will begin ...

The new Bolt will start under $30,000, which should make it a welcome addition to the stubbornly expensive EV market in the US. The new Bolt will start under $30,000, which should make it a welcome ...

In a market where federal tax credits are no longer cushioning electric car prices, the upcoming 2027 Chevrolet Bolt arrives as GM’s latest attempt to keep affordable EVs within reach. Shown off ...

Bolt Biotherapeutics has halved its workforce for the second time in two years as the oncology biotech delays a readout of its lead immunotherapy. The company had previously been expecting initial ...